Streetbeat News

Stock Prices

XYF

X Financial's stock price has declined following the announcement of a year-over-year decrease in its Q4 adjusted earnings per ADS.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 4:48 pm

OGI

OrganiGram Holdings Inc (NASDAQ:OGI) shares dropped 19% to $2.17 after announcing an overnight marketed public offering of 7.74 million units at C$3.23 each, totaling C$25 million. The offering includes an option for underwriters to purchase an additional 1.161 million units and is expected to close around April 2. The proceeds are intended for growth initiatives and general corporate purposes.

Portfolio Pulse from Henry Khederian

March 27, 2024 | 4:47 pm

Deep-pocketed investors have shown a significant bearish sentiment towards Boeing (NYSE:BA), as revealed by Benzinga's tracking of public options records. The analysis of 36 extraordinary options activities indicates a divided mood among investors, with 41% bullish and 58% bearish. Notable options activity includes both puts and calls with a total trade price in the millions and expectations of Boeing's price movement between $100.0 to $330.0. Boeing's current market standing shows a slight increase in stock price, with an upcoming earnings announcement. Analyst opinions vary, with target prices ranging from $230 to $250.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 4:46 pm

DOW

High-rolling investors have shown a bullish sentiment on Dow (NYSE:DOW), with Benzinga's options scanner revealing 8 significant trades. The sentiment is predominantly bullish with 62% and bearish at 37%. The trades include one put at $30,000 and seven calls totaling $685,027, targeting a price window of $50.0 to $60.0. The largest trades were bullish calls for strike prices of $57.50 and $55.00, and bearish calls for $60.00 and $59.00. Dow's stock is up by 0.68%, with a trading volume of 2,064,900 and an RSI indicating a potential overbought condition.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 4:46 pm

TSLA

Brad Gerstner of Altimeter announced live on CNBC that he has purchased shares of Tesla.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 4:45 pm

SNX

TD SYNNEX Corporation (NYSE:SNX) reported Q1 earnings surpassing expectations with an EPS of $2.99 against a forecast of $2.84, despite missing revenue estimates. The company announced a $2 billion share repurchase program and a quarterly dividend of $0.40 per share. For Q2, TD SYNNEX anticipates revenues between $13.3 billion and $14.9 billion, with an adjusted EPS of $2.50-$3.00. Following the earnings report, Barclays and RBC Capital raised their price targets for SNX to $118.

Portfolio Pulse from Avi Kapoor

March 27, 2024 | 4:43 pm

GOOGL

Brad Gerstner of Altimeter announced live on CNBC that they have purchased shares of Alphabet Inc. - Class A.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 4:38 pm

BYDDF

BYDDY

BYD Company aims to significantly increase its international sales of electric vehicles (EVs) to 500,000 units in 2024, doubling from the previous year, with a goal to reach 3.6 million units in total sales. This ambitious target comes amid a period of slowing profit growth and increased competition in the EV market. Despite a potential drop in vehicle margins due to price competition, BYD is focused on profitability through enhanced sales strategies and the introduction of new, more efficient models.

Portfolio Pulse from Shivani Kumaresan

March 27, 2024 | 4:36 pm

AGAE

CZOO

DOGZ

GME

HOUR

JOAN

STKS

In Wednesday's intraday session, 12 consumer discretionary stocks showed significant movement. Notable gainers included Cazoo Gr (CZOO) with an 82.6% increase and The One Group Hospitality (STKS) rising 23.31%. Among the losers, Dogness (DOGZ) fell by 16% and JOANN (JOAN) dropped 15.46%. Earnings reports influenced several stocks, including Allied Gaming (AGAE), Hour Loop (HOUR), and GameStop (GME).

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 4:31 pm

AKLI

LIXT

MESO

STOK

Health care stocks showed significant movement in Wednesday's intraday session, with notable gainers including Stoke Therapeutics (STOK) up 46.1% following their Q4 earnings release, and Lixte Biotechnology (LIXT) rising 43.68%. On the losing end, Akili (AKLI) dropped 18.8%, and Mesoblast (MESO) declined by 12.85%. Other companies like Nuvation Bio (NUVB), Ontrak (OTRK), PAVmed (PAVM), and Nutriband (NTRB) also saw substantial gains, while Salarius Pharmaceuticals (SLRX), XTL Biopharmaceuticals (XTLB), Fresh2 Group (FRES), and PDS Biotechnology (PDSB) experienced declines.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 4:31 pm